Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Abbott signs paclitaxel agreement with NaPro BioTherapeutics

July 29, 1999

Novel epipodophyllotoxin derivatives with excellent antitumor activity

July 28, 1999

Asmarine A and B: novel cytotoxic alkaloids produced by marine organism

July 28, 1999

Kinetek initiates development of ILK and PKB inhibitors for cancer therapy

July 28, 1999

Bayer presents new anticancer compounds that inhibit Raf kinase

July 27, 1999

Paxene approved for E.U. marketing; Paxoral shows positive results in phase I

July 26, 1999

Valentis initiates phase I/II trial of IL-12 gene therapy

July 26, 1999

Extremely potent cytotoxic cryptophycin analogue discovered at Lilly

July 23, 1999

CDK2-inhibitory purine derivatives with potential in cancer therapy

July 23, 1999

UBCLE: a new protein discovered at Incyte; antagonists useful for cancer, etc.

July 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...